Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie - 1 Jan 2015

Negură Lucian, Duşa Cristian Petru, Balmuş Miruna Ioana, Azoicăi Doina, Negură Anca Mihaela, Marinca Mihai Vasile, Miron Lucian

Abstract excerpt

Developed two decades ago, oncogenetic medical practice mainly concern breast, ovarian and colorectal cancers, and is targeting the hereditary risk factor, the only one that shows positive predictive value justifying the molecular diagnosis. Screening for BRCA1 and BRCA2 gene mutations is standard practice today for hereditary breast and ovarian cancer (HBOC) families in developed countries, offering the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to Breast Neoplasms

Share to Founder Effect

Share to Neoplasm Recurrence, Local

Share to Romania

Share to Young Adult

Source

Identifiers

PMID: 26193202

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.PMID 26193202Read ↗

Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.Semantic proximity Read ↗

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Semantic proximity Read ↗

Founder mutations in BRCA1 and BRCA2 genes.Semantic proximity Read ↗

A high proportion of founder BRCA1 mutations in Polish breast cancer families.Semantic proximity Read ↗

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.Semantic proximity Read ↗

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.Semantic proximity Read ↗

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.Semantic proximity Read ↗

Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases.Semantic proximity Read ↗

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.Semantic proximity Read ↗

Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North AfricaSemantic proximity Read ↗

BRCA1 and BRCA2 mutation testing in Cyprus; a population based study.Semantic proximity Read ↗

Two founder BRCA2 mutations predispose to breast cancer in young women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.